0000899243-15-001606.txt : 20150724
0000899243-15-001606.hdr.sgml : 20150724
20150724163753
ACCESSION NUMBER: 0000899243-15-001606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150722
FILED AS OF DATE: 20150724
DATE AS OF CHANGE: 20150724
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alexza Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001344413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770567768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650.944.7000
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING THOMAS BRAXTON
CENTRAL INDEX KEY: 0001279309
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51820
FILM NUMBER: 151005002
MAIL ADDRESS:
STREET 1: 91 JAMES AVENUE
CITY: ATHERTON
STATE: CA
ZIP: 94027
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-22
0
0001344413
Alexza Pharmaceuticals Inc.
ALXA
0001279309
KING THOMAS BRAXTON
C/O ALEXZA PHARMACEUTICALS, INC.
2091 STIERLIN COURT
MOUNTAIN VIEW
CA
94043
1
1
0
0
President and CEO
Stock Option (right to buy)
1.08
2015-07-22
4
A
0
400000
0.00
A
2025-07-21
Common Stock
400000
400000
D
Grant to the Reporting Person of a stock option under the Issuer's 2015 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments commencing on August 21, 2015, provided, that in each case, the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan, and provided further, that in the event that the Company terminates the Reporting Person's employment as of or within three (3) months prior to or twelve (12) months following a Change in Control (as defined in the Plan), then the option shall become fully vested and immediately exercisable as of such date. The option expires ten years after the date of grant.
/s/ Brent D. Fassett, Attorney-in Fact
2015-07-24